Hear from our CEO, Adrian Treverton, about treating non-melanoma skin cancer patients safely during COVID. Patients most likely to develop basal or squamous cell carcinoma are those in the age range at greater risk of serious illness from COVID, so safe and short treatment options are important.
Expanding Patient-Centric Treatment Options for NMSC with Radiation Therapy
Dermatologists are frequently leading the way in the diagnosis and management of non-melanoma skin cancer (NMSC). While Mohs surgery is the standard of care in the treatment of NMSC, the final decision on treatment for the patient should be based on their health, age,...